Atlas Trials

Use of Activated Recombinant Human Factor VII to Reduce Bleeding Caused by Warfarin Treatment

Clinical trial NCT01561937 · COMPLETED

Trial details

NCT number
NCT01561937
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HaemostasisHealthy
Start date
2007-01-01
Primary completion
2008-07-01
Enrollment
127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.